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Abstract
BACKGROUND: Low cognitive function has been shown to be an independent predictor of
all-cause and cardiovascular disease (CVD)-related mortality. Social support network size and
total physical activity volume (TPAV) are two modifiable factors which have been shown to be
independently associated with cognitive function and mortality risk. Therefore, the purpose of
this study was to examine the potential mediating effects of social support network size and
TPAV on cognitive function and all-cause and CVD-related mortality risk in a large, nationally
representative sample of U.S. adults.
METHODS: Study sample (N =2,550) included older adult (≥ 60 years of age) participants in
the 1999-2002 National Health and Nutrition Examination Survey. Quartiles of cognitive
function were created using Digit Symbol Substitution Test scores. Social support network size
was determined using the number of reported close friends. TPAV was determined from selfreported domestic, transportation, and leisure time physical activity.
RESULTS: Regression analysis revealed an approximate three-fold increase in all-cause and
CVD-related mortality risk in participants in the lowest quartile of cognitive function, compared
to the highest quartile of cognitive function. These relationships are independent of social
support network size and TPAV. Linear and non-linear inverse dose-response relationships were
also revealed between cognitive function and increased all-cause and CVD-related mortality risk,
respectively (P for trend for both P < 0.0001).
CONCLUSION: In a large, nationally representative sample of U.S. older adults, low cognitive
function was associated with increased all-cause and CVD-related mortality risk. However, both
relationships were independent of social support network size and TPAV.
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Chapter One: Introduction
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Cognitive function has been defined as the performance of mental processes including
perception, learning, memory, understanding, awareness, reasoning, judgement, intuition, and
language (1). Different domains of cognitive function have been identified and include language,
learning and memory, social cognition, complex attention, executive function, and perceptualmotor function (2). Different domains of cognitive function are also differentially influenced by
aging. Executive function, new learning, working memory, prospective memory, visuospatial
judgement, and the ability to perceive spatial orientation decline with age (3). However,
language, immediate memory, and procedural memories remain relatively stable with aging.
Throughout the aging process, cognitive function has important implications for
longevity. In middle aged and older populations, low cognitive function has been shown to be
associated with all-cause and cardiovascular disease (CVD)-related mortality (4-6). Several
mechanisms have been proposed to account for the association between low cognitive function
and mortality risk, including health literacy, frailty, and the beginning pathophysiology of
dementia (6).
When examining modifiable factors related to the relationship between cognitive function
and mortality which may be targeted, social support and physical activity have been shown to be
independently related to cognitive function and mortality. In high-functioning older adults,
greater baseline emotional support has been predictive of better cognitive function following 7.5
years of follow-up (7). Additionally, lower levels of social support (or an absence of social
support) have been shown to be linked to an increased mortality risk. In a 2013 meta-analysis
analyzing the associations between social support and all-cause mortality risk, individuals with
lower levels of social support exhibited a significant increase in all-cause mortality risk (8).
When examining the relationship between physical activity and cognitive function, physical
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activity has been posited to attenuate cognitive decline through increasing high-density
lipoprotein cholesterol (HDL-C), lowering systolic blood pressure, and generally improving
CVD-related risk (9). In older adults ≥ 65 years of age, physical activity has been shown to be
inversely associated with all-cause mortality risk (10).
This chapter includes relevant background information pertaining to cognitive function,
social support, and physical activity, which is followed by a focused literature review regarding
the relationship between these variables. This chapter concludes with the purpose and
significance of the research, a project description, and limitations inherent to the study design.

4
Background
Cognitive Function
Cognitive deterioration is a normal aspect of the aging process (3, 11). In a 2014 crosssectional study, Hoogendam et al. (11) reported that the effect of age on cognitive function was
already apparent in adults 45 years and older. These investigators found that a general cognitive
factor (i.e., analysis incorporating elements of the Stroop Test, Letter-Digit Substitution Task,
verbal fluency test, 15-word verbal learning test, design organization test, and the Purdue
pegboard test) showed decline starting at age 45 and a quadratic effect of age was found for both
the general cognitive factor and the Mini-Mental State Examination. Therefore, cognitive decline
does not occur suddenly in older adulthood, but can begin in middle age with declines in general
cognition, suggesting the importance of identifying factors which may attenuate age-related
cognitive decline.
A rapidly aging population can indicate an increasing prevalence of age-related cognitive
decline and neurocognitive disease. An estimated 14.5% (46.3 million) of the U.S. population
were aged 65 or older in 2014 and this is projected to approximately double and reach 23.5% (98
million) by 2060 (12). With an increase in the proportion of older adults living in the United
States (U.S), the prevalence of neurocognitive disorders can be expected to increase. In 2020, the
prevalence of mild cognitive impairment (MCI), an intermediate stage between normal cognitive
function and dementia, was 22.7%, and the prevalence of clinical Alzheimer’s Disease (AD) was
11.3% in the United States (13). With an increasing prevalence of MCI, dementia risk
concurrently increases because individuals with MCI have a high rate of progression to dementia
(14). Moreover, it is not only important to identify factors which may attenuate age-related
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cognitive decline, but it is important to identify factors which limit the progression from MCI to
dementia.
During the aging process, functional, and structural changes occur in the brain which
influence cognition and may contribute to the process of cognitive decline or the
pathophysiology of neurocognitive disease. First, aging differentially affects the various domains
of cognitive function. While speech, language, immediate memory, and procedural memory
remain relatively stable with age, more complex cognitive tasks such as selective attention,
divided attention, recent memory, prospective memory, executive function, processing speed,
and visual perceptual judgment decline with age (3, 11, 15). Changes in brain structure also
occur during the aging process which augment the process of cognitive decline. In the brain, gray
matter includes the cerebral and cerebellar cortex which consists predominantly of cell bodies
and dendrites and white matter includes the regions of the brain with myelinated axons
connecting gray matter structures (3). While both gray matter and white matter are affected by
aging, gray matter loss is most prominent in the prefrontal cortex, while the greatest white matter
loss occurs in the frontal lobe and corpus callosum. Because the most important function of the
prefrontal cortex is executive function, grey matter loss in the prefrontal cortex may account for
the decline in executive function associated with age (16). Age-related changes are also found in
the temporal lobes, where decreases in the volume of the hippocampus have been observed,
subsequently influencing memory throughout the aging process (15). The importance of synaptic
density has also been highlighted in dementia research, indicating that symptomatic dementia
occurs when there is at least a 40% loss of neocortical synapses (3).
Moreover, cognitive decline is an inherent component of the aging process. However,
cognitive decline and low cognitive function have deleterious effects on health outcomes.
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Cognitive function has been shown to be associated with both all-cause and cause-specific
mortality (i.e., death from cancer, CVD, and respiratory illness) (4-6, 17-18). In addition,
cognitive function has been associated with a variety of other health outcomes including quality
of life (19) and non-fatal CVD events including angina pectoris, myocardial infarction, and
stroke (20). Because age-related changes in cognitive function have been established, assessment
of cognitive function throughout the aging process remains important due to its implications for
prognosis. Additionally, because mortality risk, quality of life, and CVD risk may be linked to
modifiable lifestyle factors such as social support and physical activity, it remains important to
examine how these factors influence the association between cognitive function and health
outcomes.
Social Support
Social support has been defined as assistance which is accessible to an individual through
social ties to other individuals, groups, and/or the larger community (21). The three most
common types of social support include emotional, instrumental, and informational support (22).
Emotional support is characterized by the availability of esteem, trust, concern, and listening.
Instrumental support consists of the provision of tangible support, such as in aid or labor. Lastly,
informational support is the availability of advice or information.
The presence, or absence, of social support has important implications for health
outcomes. Social isolation and low levels of social support have been shown to be associated
with mortality (7, 23), depression (24), and coronary heart disease (CHD) (25). The effects of
social support on life expectancy have been reported to be as strong as the effects of obesity,
cigarette smoking, hypertension, and physical activity level (26). Social support has been posited
to improve health outcomes by targeting an individual’s psychological state, behavior, and
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response to stress (22). This phenomenon occurs as social support reduces CV reactivity to acute
stress (27). Consequently, a lack of social support is associated with increased sympathetic
nervous system activation and can result in increased levels of urinary norepinephrine, increased
levels of plasma adrenaline, and elevations in both systolic and diastolic blood pressure (27).
Additionally, social support may improve both mental and physical health by influencing
behavior and reducing the rate at which individuals engage in risky behaviors, prevent negative
appraisals, and increase treatment adherence (26).
Social support has also been shown to be associated with cognitive function. In a 2021
systematic review, a positive association was observed between social support and cognition
(28). Social support included emotional support, satisfaction with support, positive or negative
interactions, instrumental support, informational support, someone to share personal feelings and
experiences with, and help with decision making. Among the 22 studies examined, global
cognition (i.e., assessed with measures of global or composite cognitive function) was most
frequently associated with social support and emotional support was associated with
improvements on four out of five global cognition measures. In older adults, lower levels of
social support were associated with a greater probability of cognitive deterioration. Therefore,
social support may be an important target in order to maintain cognitive function in older
adulthood. These investigators also examined the association between social networks and
cognitive function. Social networks were defined as living arrangements, marital status, number
of social ties, or frequency of contact with friends and family. Social network size and higher
frequency of contact was also associated with global cognition.
The association between social support and cognitive function may be partially explained
by the interactional brain hypothesis. The interactional brain hypothesis suggests that interactions
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with others are a constitutive component of brain development and cognitive processes,
regardless of whether the social interaction is virtual, implied, real, imagined, momentary, or
continuing (29). Therefore, this theory suggests that social interactions with others in old age
may function to maintain cognitive processes during aging. However, it should also be noted that
changes in the characteristics of social relationships could occur because of cognitive decline, as
opposed to being the cause of cognitive decline. In old age, cognitive decline may result in a
generalized inability to function socially and lead to social withdrawal due to a failing memory
or word-finding difficulties which attenuate self-efficacy (28).
Physical Activity
Physical activity has been defined as any bodily movement which is produced by skeletal
muscles and results in energy expenditure (30). Four domains of physical activity have been
established which include leisure time physical activity, occupational physical activity,
transportation physical activity, and domestic physical activity. Leisure time physical activity
consists of physical activity an individual engages in during their free time which is often based
on interests and needs (31). By contrast, occupational physical activity is associated with an
individual’s physical job requirements. Next, transportation or commuting physical activity
consists of physical activity performed when moving from place to place. Lastly, domestic
physical activity consists of physical activity performed while working at home such as
housework, gardening, general maintenance, or caring for one’s family (32).
Similar to cognitive function and social support, physical activity has been shown to be
positively associated with several health outcomes including CVD, quality of life, and
depression. A 2012 meta-analysis of prospective cohort studies reported significant reductions in
CVD risk (i.e., risk of incident CHD and stroke) in men and women engaging in a high level of
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leisure time physical activity and a moderate level of occupational physical activity (33). When
assessing the association between physical activity and quality of life, a 2012 systematic review
reported that higher levels of physical activity were associated with better perceptions of quality
of life in older adults, apparently healthy adults, and adults with various health conditions
including CVD, overweight/obesity, hypertension, diabetes, and cancer (34). Lastly, increased
physical activity volume has been shown to be inversely associated with depression levels and
symptoms in individuals of all ages (35).
Physical activity is also important for maintaining longevity. A 2008 meta-analysis
conducted by Nocon et al. (36) reported that physical activity is associated with a marked
reduction in CVD-related mortality and all-cause mortality. The researchers found that changes
in physical activity volume are important for reducing mortality risk in those who may be
insufficiently active or sedentary, in addition to baseline physical activity level. In a 2019
population-based cohort study, long term increases in physical activity volume were associated
with significant reductions in all-cause, CVD-related, and cancer-related mortality (37). These
investigators also reported that meeting and maintaining the World Health Organization
minimum physical activity guidelines of 150 minutes/week of moderate-intensity physical
activity could potentially prevent 46% of deaths associated with physical inactivity.
Physical activity has also been shown to enhance existing cognitive function and prevent
or delay the progression of cognitive disease (38, 39). In older adults, both acute and long-term
moderate to vigorous intensity physical activity have been shown to improve brain structure,
brain function, and cognition (39). This was supported by a 2019 prospective cohort study
examining the associations between physical activity and trajectories of cognitive performance
over a maximum 27-year follow up in community dwelling older adults (40). These investigators
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reported that current physical activity was associated with better cognitive function on all
cognitive tests (i.e., the Mini-Mental State Exam, Trails Making Test Part B, category fluency
tests, and the Buschke-Fuld Selective Reminding Test) with advancing age. The investigators
also noted that the highest global cognitive function throughout aging was maintained in
individuals who were physically active (i.e., engaging in any level of physical activity at least
three times per week) at age 30 and older, suggesting that physical activity in early life may
promote brain changes and establish a “cognitive reserve” which may protect against cognitive
deficits in older adulthood.
Not only is physical activity important for maintaining and improving cognitive function
during normal aging, but physical activity can influence an individual’s progression and risk of
neurocognitive disease. There is strong evidence that greater amounts of physical activity reduce
the risk for cognitive impairment in individuals at risk for dementia and cognitive impairment
(39). In adults with dementia, there is moderate evidence suggesting that physical activity may
improve cognitive function. Therefore, not only can increased physical activity volume attenuate
the effects of age-related cognitive decline, but it can also be utilized to reduce the risk of
neurocognitive disease and improve prognosis following diagnosis.
Focused Literature Review
Existing literature has demonstrated an increased mortality risk for those with low
cognitive function, while establishing inverse associations between increased cognitive function,
social support, physical activity volume, and mortality risk. These associations have been
established independent of one another, and there are few investigations determining whether
social support and physical activity mediate the association between cognitive function and
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mortality risk. Furthermore, data examining these associations in large, nationally representative
samples of the U.S. population are sparse.
Purpose and Significance
The purpose of this study is to examine the potential mediating effects of social support
and physical activity on the association between cognitive function and all-cause and CVDrelated mortality risk in a nationally representative sample of U.S. older adults ≥ 60 years of age.
The primary aim of this study was to examine the following:
1. Do social support and total physical activity volume (TPAV) mediate the association
between cognitive function and mortality risk?
To the extent of our knowledge, this is the first study to examine whether social support and
TPAV mediate the association between cognitive function and all-cause and CVD-related
mortality risk in a nationally representative sample of U.S. older adults ≥ 60 years of age who
participated in the 1999-2002 National Health and Nutrition Examination Survey (NHANES). It
was hypothesized that social support network size and TPAV mediate the relationship between
cognitive function and mortality risk, due to the independent associations between the variables.
Project Description
The NHANES is a continuous program conducted by the National Center for Health
Statistics which collects data about the health, nutritional status, and health behaviors of the noninstitutionalized civilian population of the U.S. by combining personal interviews with
standardized physical examinations and laboratory tests (41). The final sample in this study
consisted of 2,550 men and women ≥ 60 years of age in the 1999-2002 NHANES. Cox
proportional hazards regression analysis was conducted to determine the cumulative risk of all-
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cause and CVD-related mortality according to cognitive function level. Limitations inherent to
the study design include:
1. The inability to track potential changes in cognitive function between initial
measurement and death.
2. Causality cannot be established due to the cross-sectional design of the study.
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Chapter Two: Review of Literature
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Cognitive function has been established as an independent risk factor for all-cause and
CVD-related mortality risk in middle aged and older adults (1-5). In a 2003 study examining the
association between cognitive function and all-cause mortality in middle aged adults (48-67
years of age), higher cognitive function was associated with significant reductions in all-cause
mortality risk (1). These investigators concluded that cognitive function assessed in middle age
appears to have prognostic value for life expectancy similar to that reported in older adults. In a
subsequent 2020 study examining adults ages 45-72 years of age, investigators found that both a
composite score of cognitive function and individual measures of cognitive function (i.e.,
measures of immediate verbal recall, delayed verbal recall, semantic verbal fluency, and
cognitive speed and attention) were associated with all-cause and CVD-related mortality during
10-years of follow-up (2). Baseline cognitive function has also been shown to be predictive of
all-cause mortality in older community dwelling adults (3) and the association between cognitive
function and all-cause mortality risk has been shown to be independent of CVD biomarkers (i.e.,
mean arterial pressure, high-sensitivity CRP, high-density lipoprotein cholesterol (HDL-C), total
cholesterol, glycosylated hemoglobin (HbA1c), and body mass index (4).
Because of the established role of cognitive function as an independent risk factor for allcause and CVD-related mortality, it is important to identify factors that may mediate this
association to attenuate mortality risk. Social support and physical activity are two lifestyle
factors which have been shown to be independently associated with both cognitive function and
mortality. Therefore, social support and physical activity may be potential factors which mediate
the association between cognitive function and mortality.
Social support has been shown to independently predict cognitive functioning
independent of socio-economic status, health behaviors, and physical health (6). Better cognitive
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function has been found in individuals with larger social networks and social participation (6),
while poor social relationships have been associated with greater levels of cognitive decline (7).
In older adults, different aspects of social relationships have been shown to influence cognitive
function. Social activity (i.e., attending social interactions, field trips, travel, outings, visiting and
receiving visitors, participation in voluntary activities, religious activities, membership in
community groups, or social groups) has been shown to be positively associated with global
cognition, executive function, working memory, visuospatial abilities, and processing speed in
healthy, older adults (8). Global cognition is also positively associated with social networks (i.e.,
living arrangements, marital status, number of social ties or frequency of contact with friends and
family) and social support (i.e., emotional support, satisfaction with support, positive or negative
interactions, instrumental support, or informational support) in older adults.
An association between social support and mortality has also been established. A 2013
meta-analysis analyzing the association between social support and all-cause mortality found that
individuals with lower levels of social support exhibited an average 11% increase in all-cause
mortality risk and the importance of having social support increased with age (9). Moreover,
social support has been posited to be a function of an individual’s social network, highlighting
the importance of examining the role of social support network size when relating social support
to mortality. This was supported by a 2017 longitudinal study which found a 33% reduction in
all-cause mortality risk in older adults (≥ 60 years of age) with a social support network size of
greater than or equal to 9 members (10).
Physical activity has also been shown to be related to cognitive function. Physical activity
induces important structural and functional changes in the brain which improve brain plasticity
and subsequently influence cognitive function and overall wellbeing (11). Physical activity is
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also a protective factor against neurodegeneration (11). In older adults at risk for Alzheimer’s
Disease, significant improvements in cognitive function were observed following a six-week
physical activity intervention when compared to participants who completed usual care (12).
Improvements in cognitive function following a physical activity intervention have also been
observed in healthy adults. In a 2010 meta-analysis of healthy adults ≥ 18 years of age, aerobic
exercise was associated with a modest improvement in neurocognitive function (i.e.,
improvements in attention, processing speed, executive function, and memory) (13).
Terminology
Cognitive function refers to multidimensional mental abilities which include learning,
thinking, reasoning, remembering, problem solving, decision making, and attention (14). The
Diagnostic and Statistical Manual of Mental Disorders, 5 th edition (DSM-5) identifies six
domains of cognitive function including language, learning and memory, social cognition,
complex attention, executive function, and perceptual-motor function (15). Within each domain
of cognitive function, the DSM-5 has also established subdomains of cognitive function. Figure
1 illustrates the six domains and subdomains of cognitive function.
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Figure 1. Neurocognitive Domains according to the DSM-5.
Note. Adapted from, “Classifying Neurocognitive Disorders: The DSM-5 Approach” by
Sachdev et al. Nature Reviews Neurology. 2014;10(11), 634-642.

Social support has been defined as support which is accessible to an individual through
social ties to other individuals, groups, or the larger community (16). Social support network size
has been defined as a personal network which consists of people (e.g., a spouse, children,
relatives, neighbors, friends, fellow members of organizations, and acquaintances) the individual
has direct, personal relationships with (17). Within NHANES, social support network size has
been characterized using the self-reported number of close friends (18-20).
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Physical activity has been defined as any bodily movement produced by skeletal muscles
which results in energy expenditure (21). There are four domains of physical activity which
include leisure-time physical activity, occupational physical activity, transportation physical
activity, and domestic physical activity. Leisure-time physical activity describes the activities an
individual participates in during their free time which are based on personal interests (22). By
contrast, occupational physical activity describes physical activity associated with the
performance of a job. Transportation physical activity consists of physical activity performed
with the purpose of going somewhere (e.g., walking, bicycling, climbing/descending stairs to
public transportation) (23). Lastly, domestic physical activity consists of housework, yard work,
childcare, chores, or self-care.
Cognitive Function
Cognitive function is an important predictor of health outcomes and different components
of cognitive function are predictive of the development of neurodegenerative disease. In 2006,
Bennett et al. conducted a prospective cohort study to examine how cognitive function is related
to Alzheimer’s Disease pathology (24). These investigators reported that the average global
cognitive score was approximately 0.6 units lower for each unit of global disease pathology (i.e.,
based on a composite score of the number of neuritic plaques, diffuse plaques, neurofibrillary
tangles, and amyloid-β deposits). These investigators concluded that cognitive function is
inversely related to Alzheimer’s Disease pathology. A subsequent 2009 study analyzed the
associations between premorbid cognitive function, current cognitive function, and the clinical
features of patients with Alzheimer’s Disease, mild cognitive impairment, and subjective
cognitive impairment (25). These investigators found that cognitive function assessed by a
battery of neuropsychological tests varied in accordance with what would be expected over the
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course of neurodegenerative disease progression. Moreover, cognitive decline significantly
predicted cerebrospinal fluid amyloid b protein (ΑΒ 42) load and total tau protein, both indices of
neurodegeneration and Alzheimer’s Disease progression. Therefore, cognitive function is an
important measure throughout the aging process due to its diagnostic and prognostic value
concerning neurodegenerative disease.
Cognitive function has also been shown to be predictive of cardiovascular disease. In
2005, Elkins et al. conducted a prospective cohort study examining whether impaired cognitive
function reflects an early manifestation of vascular injury in the brain and whether impaired
cognitive function predicts the development of CVD (26). These investigators reported that
lower scores of cognitive function were associated with a significant increase in the risk of
cardiovascular events (e.g., myocardial infarction, death from CHD, and stroke) and the
magnitude of the association was comparable to other established predictors of CVD risk
including left ventricular hypertrophy on EKG and an HDL-C level < 35 mg/dL. A subsequent
2021 study supported this finding and found that a decrease per one standard deviation in a
composite score of cognitive function and different cognitive function scores (e.g., immediate
verbal recall and delayed verbal recall) resulted in a significant increase in risk of participants
experiencing their first event of CVD (e.g., unstable angina pectoris, acute myocardial infarction,
and stroke (27).
In addition to neurodegenerative and cardiovascular disease, cognitive function is
associated with all-cause and cause-specific mortality in middle aged and older population (5,
28-32). In 2003, Pavlik et al. examined whether an inverse association between cognitive
function and all-cause mortality exists in middle aged adults, similar to the association observed
in older adults (28). Three measures of cognitive function were utilized which included the Digit
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Symbol Substitution Test, Delayed Word Recall Test, and the Word Fluency Test. Following full
adjustment, significant reductions in all-cause mortality risk were observed for every one-point
score increment on the Delayed Word Recall Test and every seven-point score increment on the
Digit Symbol Substitution Test. These investigators concluded that cognitive function is a robust
predictor of all-cause mortality in middle-aged adults and cognitive function has important
prognostic importance for life expectancy, like what has been observed in older adult
populations.
A subsequent 2020 study examined the association between baseline cognitive function,
cognitive transition, and all-cause mortality in community-dwelling older adults (≥ 65 years of
age) (29). Cognitive function was assessed with the Mini-Mental State Examination and
cognitive function was dichotomized as cognitive impairment and normal cognitive function,
while accounting for education level. After a mean follow-up of 6.62 years, a two-fold increase
in all-cause mortality risk was observed in participants with baseline cognitive impairment.
These investigators also expanded on previous literature by examining cognitive transition in this
population. Interestingly, individuals who reverted from impaired to normal and individuals
whose cognitive function remained impaired over a one-year period exhibited an approximate
three-fold and four-fold increase in all-cause mortality risk, respectively. No significant increases
in all-cause mortality risk were observed in participants who had normal cognitive function at
baseline. These results suggest that baseline cognitive function may exert a greater influence on
mortality risk than cognitive transition over a one-year period.
When examining cause-specific mortality, a 2016 study examined the association
between general cognitive function in middle and older age and the subsequent risk of death
from chronic diseases (5). Cognitive function was assessed with a battery of neuropsychologic
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tests which examined three domains of cognitive function including memory, executive function,
and processing speed. Following nine years of follow-up, these investigators reported that for
each one standard deviation decrease in cognitive function, there was a 49%, 13%, and 97%
increase in the risk of CVD-related, cancer-related, and respiratory illness-related mortality,
respectively. The association between cognitive function and CVD-related mortality was
expanded on in a 2018 study conducted by An et al. (32). In adults ≥ 55 years at baseline, low
cognitive function assessed with the Mini-Mental State Examination was associated with a
significant increase in CVD-related mortality. These investigators reported that participants in
the lowest quartile of cognitive function exhibited a 4.5-fold increase in CVD-related mortality
risk and for every five-point decrease in Mini-Mental State Examination score, a 56% increase in
CVD-related mortality was observed. Furthermore, low cognitive function has important
prognostic value for cause-specific mortality in addition to all-cause mortality.
Social Support
Classic and current models of successful aging, such as those proposed by Young and
colleagues and Rowe and Kahn, posit that social functioning (i.e., a multidimensional component
which includes loneliness, social activity, instrumental support, and emotional support) is a key
factor for healthy and successful aging (33, 34). This has been reflected in previous evidence,
which has suggested an inverse association between social support and health-damaging
behaviors including tobacco use, alcohol consumption, physical inactivity, and obesity (35). The
association between social support and health-damaging behaviors subsequently elucidates an
association between social support and CVD risk. In older adults ≥ 70 years of age, social
isolation and low social support have been shown to be associated with a 66% and two-fold
increase in CVD risk, respectively (36). The augmented CVD risk in individuals may be
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attributed to social support’s influence on CVD risk factors. In a 2006 cross-sectional study
conducted by Hawkley et al. (37), an absence of social support (i.e., loneliness) was associated
with elevated systolic blood pressure and age-related increases in systolic blood pressure in
adults 50-68 years of age. Additionally, significantly greater coronary atherosclerosis has been
reported in women (ages 30-65 years) with social isolation, in women who lacked emotional
support, and in women who had a lack of interpersonal social relations (38). Therefore, both
social support and lack of social support have important implications for health outcomes during
the aging process.
In addition to cardiovascular health, social support has important implications for
cognitive function throughout the aging process. The interactional brain hypothesis suggests that
social interaction is a constitutive component in the development and operation of brain
mechanisms, whether the individual is engaged in an interactive situation or not (39). In a 2021
systematic review of 22 studies, a positive association between social support and cognition was
reported and the importance of social support was found to increase with age (40). During older
adulthood, the researchers also found that emotional support (i.e., the provision and availability
of esteem, trust, concern, listening, and love) and instrumental support (i.e., the provision of
assistance with concrete needs, such as aid in money or labor) were two key dimensions in the
relationship between social support and cognition (41). Therefore, the importance of functional
social relationships (i.e., the social and emotional resources which are provided by others, or the
perception of their provision) during older adulthood has been revealed (42).
In addition to the importance of functional social relationships during the aging process,
the size of one’s social support network has also been shown to influence cognitive function,
revealing the importance of structural social relationships. Structural social relationships reflect
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participation in a broad range of social relationships and refer to the quantitative characteristics
of social relationships (42, 43). In 2004, Barnes et al. conducted a prospective cohort study to
examine the association between social resources, cognitive function, and cognitive decline in
older adults ≥ 65 years of age (44). Two measures were utilized to assess an individual’s social
resources, including social network size and social engagement. Social network size was based
on the number of children, relatives, and friends the participant saw at least one a month, while
social engagement was assessed with four items related to social and productive activity. These
investigators reported that larger social network sizes and greater social engagement were
positively correlated with baseline level of cognitive function (P < 0.001 for both). In addition,
both social network size and social engagement were associated with an attenuated rate of
cognitive decline. Individuals in the 90 th percentile of social network size had a 39% reduction in
the rate of cognitive decline when compared to participants in the 10 th percentile of cognitive
decline. Individuals with high social engagement reduced the rate of cognitive decline by 91%.
When examining older adults ages 80-98 years of age, similar findings were reported in a
2021 study which examined the associations between aspects of social engagement (i.e., social
network size, social support, social isolation, and loneliness) and health outcomes (45). These
investigators reported that larger social support network sizes were associated with better scores
on a composite measure of cognition. These investigators concluded that larger social support
networks provide greater opportunities for both social engagement and social support in older
adulthood. Additionally, a 2017 systematic review of 39 studies found that larger social networks
were associated with better levels of global cognition in adults ≥ 50 years of age (46). Therefore,
these studies exemplify the importance of examining the association between structural social

29
relationships and cognitive function, as larger social networks have been shown to be associated
with better cognitive function.
Therefore, the associations between social support (i.e., both functional and structural
social relationships), health outcomes, and cognitive function has been established. However,
social support also has important implications for mortality risk. In 2015, Becofsky et al.
examined the associations between source of weekly social network, social support network size,
and all-cause mortality risk (47). Following a median follow-up of 13.5 years, participants who
reported social support from family and social support from a spouse/partner exhibited a 19%
reduction in all-cause mortality risk (P = 0.01 for family social support; P = 0.04 for
spouse/partner social support). When examining social support network size, participants who
reported weekly contact with six or seven close friends exhibited a 24% reduction in all-cause
mortality risk compared to participants in contact with zero or one friend. Therefore, these
investigators concluded that both social support network size and source of social support have
important health consequences related to mortality risk, exemplifying the importance of both
structural and functional social relationships for attenuating mortality risk.
In 2013, Barger also examined the association of functional and structural social
relationships with mortality (42). Using data from the U.S. National Health Interview Survey, a
social integration variable was created using eight binary questions including four questions
assessing the past two weeks contacts with relatives or friends, three questions assessing whether
the participant attended a religious service, group social activity, or went out to eat, and one
question assessing whether the participant was married or living with a partner. Social support
was assessed with the question, “How often do you get the social and emotional support you
need- always, usually, sometimes, rarely, or never?” Following five years of follow up, a 14%
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reduction in all-cause mortality risk was observed in participants with the highest social
integration. No significant reduction in all-cause mortality risk was observed in participants with
the highest levels of social support. These investigators concluded that maintaining some degree
of social relationship activity may be more important for mortality risk than the quality of the
relationships.
A subsequent 2019 prospective cohort study expanded on these results and assessed the
independent association between social integration and risks of all-cause and cause-specific
mortality using data from the U.S. National Health Interview Survey (48). Social integration was
determined using the same eight binary questions that Barger (2013) utilized. Following a mean
follow-up of 13.8 years, a 30%, 33%, and 53% reduction in the risk of all-cause, CVD-related,
and diabetes-related mortality were observed in participants with the highest level of social
integration compared to participants with the least level of social integration, respectively. These
investigators reported that the association between social integration and mortality risk was
linear and consistent across age groups, sex, income, education, and employment status. By
contrast, social support was not associated with all-cause or cause-specific mortality risk. These
results supported the findings of Barger (2013) and expanded on them by examining causespecific mortality. These investigators also reported that the association between social
integration and CVD-related mortality may be explained by previous evidence, which found that
individuals with higher levels of social integration were more likely to participate in leisure time
physical activity, were less likely to smoke or more likely to quit smoking and had better
adherence to a healthy lifestyle and medication compliance (49-51).
Two different mechanisms have been proposed which account for the association
between social support and mortality risk including the stress buffering model and the main
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effects model. The stress buffering model posits that social relationships moderate the
deleterious influences of stress on health (52). This occurs as social relationships may provide
resources which promote adaptive behavioral or neuroendocrine responses to either acute or
chronic stressors. This has been observed as social support has been shown to be associated with
reduced cortisol reactivity, diminished activity in the dorsal anterior cingulate cortex, and
diminished activity in Brodmann’s area 8 (i.e., two brain regions previously associated with the
distress of social separation) (53). By contrast, low levels of social support have been associated
with increases in heart rate, blood pressure, and exaggerated cardiovascular and neuroendocrine
responses to laboratory stressors (54).
The main effects model differs from the stress buffering model in that the main effects
model argues that social relationships are beneficial, regardless of an individual’s stress level
(55). The main effects model suggests that social relationships promote normative health
behaviors and triggers positive psychological responses (i.e., feeling loved, sense of belonging,
and security) which increase motivation to care for oneself, contentment, and favorable
physiological reactions (56). Therefore, social relationships may directly encourage or indirectly
model health behaviors (52). For example, social networks may influence whether individuals
exercise, eat low-fat foods, or smoke (55). Therefore, it is social relationships which promote
normative health behaviors and positive psychological responses, rather than the moderation of
behavioral or neuroendocrine responses, which explain the association between social support
and mortality.
Physical Activity
Physical activity is an important component of successful aging as physical activity
reduces the risk of multiple chronic diseases including CVD, thromboembolic stroke,
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hypertension, type 2 diabetes mellitus, osteoporosis, obesity, colon cancer, breast cancer,
anxiety, and depression (57). Physical activity also contributes to the maintenance of activities of
daily living throughout the aging process as physical activity reduces the risk of falls and injuries
from falls, prevents functional limitations, and can function as a therapy for many chronic
diseases. Because of the health benefits achieved with physical activity, physical activity
guidelines for older adults have been established. The 2018 Physical Activity Guidelines for
Americans recommend that older adults should perform 150-300 minutes per week of moderateintensity physical activity or perform 75-150 minutes per week of vigorous-intensity physical
activity with muscle-strengthening activities performed on at least two days per week (58).
Additionally, the 2018 Physical Activity Guidelines recommended that older adults should
engage in multicomponent physical activity such as balance training. Therefore, both performing
and maintaining physical activity are important considerations for older adults in order to
attenuate chronic disease risk, reduce fall risk, and maintain activities of daily living.
During the aging process, physical activity has also been shown to enhance existing
cognitive function and prevent or delay the onset of cognitive decline. In 2008, Lautenschlager et
al. conducted a randomized controlled trial to examine whether physical activity attenuates the
rate of cognitive decline in adults (≥ 50 years of age) at risk for Alzheimer’s Disease (12).
Participants were randomly assigned to either a 24-week home based physical activity program
(i.e., consisting of walking, aerobic exercise, and strength training) or to an education and usual
care group. Cognitive function and cognitive decline were assessed using the cognitive section of
the Alzheimer Disease Assessment Scale (ADAS-Cog). Following the 24-week intervention,
participants who completed the physical activity intervention had significantly (P = 0.04) better
ADAS-Cog scores when compared to participants in the education and usual care group. These
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investigators also reported that the participants who completed the physical activity intervention
improved an average 1.3 points on the ADAS-Cog compared to participants in the education and
usual care group. This is noteworthy because this improvement is comparable to the 0.5 point
improvement in the ADAS-Cog associated with the use of Donepezil (i.e., an
acetylcholinesterase inhibitor used to improve cognitive function in individuals with Alzheimer’s
disease). Therefore, this study suggests that physical activity enhances cognitive function in
older adults at risk for Alzheimer’s Disease and the effect of physical activity on cognitive
function is comparable to other pharmacological interventions.
While Lautenschlager et al. (2008) revealed that physical activity improves cognitive
function in adults at risk for Alzheimer’s Disease, physical activity has also been shown to
improve cognitive function in healthy, older adults. In 2021, Carta et al. conducted a randomized
controlled trial to examine whether physical activity is effective at improving cognitive function
in older adults (≥ 65 years of age) (59). Participants were randomly assigned to either a 12-week
physical activity intervention (i.e., consisting of moderate-intensity aerobic exercises, anaerobic
exercises, "life movements," strength, and balance) or a control condition (i.e., consisting of
cultural and educational activities). Cognitive function was assessed with the Italian version of
the Addenbrooke’s Cognitive Examination Revised (ACE-R). Following the 12-week
intervention, a significant (P = 0.04) improvement on the ACE-R total score was observed in
participants who completed the physical activity intervention. By contrast, no significant
improvements were observed in participants in the control condition. These investigators
concluded that moderate-intensity physical activity is associated with improvements in cognitive
function in healthy, older adults.
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Therefore, physical activity has been shown to enhance existing cognitive function in
both adults at risk for Alzheimer’s Disease and healthy, older adults. However, physical activity
also attenuates the risk of cognitive decline. In 2011, Sofi et al. conducted a meta-analysis of 15
prospective cohort studies examining the association between physical activity and cognitive
decline in healthy participants without dementia (60). Fourteen of the studies analyzed older
adults ≥ 65 years of age, while one study examined middle aged adults ages 35-55 years of age.
These investigators reported that participants who reported engaging in high levels of physical
activity had a 38% reduction in the risk of cognitive decline when compared to sedentary
participants (P < 0.00001). Additionally, participants who engaged in low-to-moderate levels of
physical activity had a 35% reduction in the risk of cognitive decline (P < 0.00001).
Furthermore, this study elucidates the importance of physical activity for attenuating the risk of
cognitive decline in healthy participants without neurodegenerative disease.
Moreover, the relationship between physical activity, cognitive function, and cognitive
decline has been established in both adults at risk for Alzheimer’s Disease and in healthy, older
adults. However, physical activity is also important for the prevention of neurodegenerative
disease including dementia and Alzheimer’s Disease. A 2008 systematic review of 16
prospective cohort studies conducted by Hamer and Chida reported that participants in the
highest category of physical activity exhibited a 28% and 45% reduction in the risk of dementia
and Alzheimer’s Disease, respectively (61). A subsequent 2015 meta-analysis of 10 prospective
cohort studies supported the findings of Hamer and Chida (2008), reporting a 39% reduction in
the risk of Alzheimer’s Disease in physically active older adults compared to non-active older
adults (62). Therefore, physical activity is very important behavior throughout the aging process
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and during older adulthood due to its protective effects against dementia and Alzheimer’s
Disease.
Various mechanisms have been posited to account for the association between physical
activity, cognitive function, cognitive decline, and the risk of neurodegenerative disease (63).
Physical activity may improve cognitive function and attenuate cognitive decline through its
actions to improve cortical connectivity, increase hippocampal volume, preserve gray matter
volumes, and facilitate neuroplasticity. Physical activity may also modify vascular risk factors
and reduce cerebrovascular burden. This has been observed through physical activity’s actions to
improve glucose intolerance, hypertension, hyperlipidemia, and obesity. When examining the
association between physical activity and neurodegenerative disease, physical activity may also
reduce the risk of neurodegenerative disease by augmenting the release of brain-derived
neurotrophic factor and insulin-like growth factor 1.
Therefore, physical activity exerts protective effects against cognitive decline and
neurodegenerative disease. However, physical activity has also been established as a protective
factor against both all-cause and CVD-related mortality. A 2008 systematic review and metaanalysis of 24 studies reported that participants reporting the highest level of physical activity
had a 35% reduction in CVD-related mortality and a 33% reduction in all-cause mortality when
compared to the least active participants (64). These findings were supported by a 2009 metaanalysis of 38 studies which found a 31% reduction in all-cause mortality risk in participants
reporting the highest level of physical activity when compared to the least active participants
(65).
Moreover, current levels of physical activity have been shown to be protective against
both all-cause and CVD-related mortality risk. However, changes in physical activity are also
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important for attenuating mortality risk. In 2019, Mok et al. examined the associations of
baseline and long-term changes in physical activity on all-cause, CVD-related, and cancerrelated mortality in middle aged and older adults 40-79 years of age (66). Following a median
follow up of 12.5 years, these investigators reported that for each 10 kJ/kg/day difference in
baseline physical activity energy expenditure between individuals, a 30% reduction in all-cause
mortality risk, a 31% reduction in CVD-related mortality risk, and a 17% reduction in cancerrelated mortality risk was observed. These investigators additionally reported that each 1
kJ/kg/day/year increase in physical activity energy expenditure was associated with a 22%
reduction in all-cause mortality risk, a 25% reduction in CVD-related mortality risk, and a 12%
reduction in cancer-related mortality risk. Moreover, the attenuated risk associated with changes
in physical activity energy expenditure occurred independent of baseline physical activity energy
expenditure. Therefore, this study suggests that changes in physical activity, not only baseline
physical activity levels, are important for reducing one’s mortality risk and promoting longevity.
Summary
In summary, low cognitive function has been established as an isolated risk factor for
both all-cause and CVD-related mortality. Because the association between cognitive function
and mortality has been shown to be independent of CVD risk factors, it is important to identify
lifestyle factors which may mediate this association. Currently, there is very limited evidence
examining whether social support and physical activity mediate the association between
cognitive function and mortality risk. Therefore, because social support and physical activity
have been shown to be independently associated with both cognitive function and mortality risk,
it is important to examine whether these factors mediate the association between cognitive
function and mortality risk to promote longevity during the aging process.
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The purpose of this study is to examine the potential mediating effects of social support
network size and physical activity on the association between cognitive function and all-cause
and cardiovascular disease (CVD)-related mortality risk. This section provides the details on the
methodology used to address the research question.
DATA COLLECTION
The National Health and Nutrition Examination Survey (NHANES) is a continuous
program conducted by the National Center for Health Statistics (NCHS). The purpose of the
NHANES is to collect data about the health, nutritional status, and health behaviors of the noninstitutionalized civilian population of the U.S. Findings from the NHANES are used to
determine the prevalence of major diseases and risk factors for diseases, to assess nutritional
status and its association with health promotion and disease prevention, and to establish national
standards for measurements such as height, weight, and blood pressure (1). The study sample
included 2,550 men and women (≥ 60 years of age) who participated in the 1999-2002
NHANES. Inclusion criteria for the sample included adults ≥ 60 years of age, individuals who
attended the mobile examination center, women who were not pregnant, and individuals who
completed data on all variables of interest.
PRIMARY DEPENDENT VARIABLE
The primary dependent variables in this study were all-cause mortality and CVD-related
mortality. All-cause mortality was defined as death from all causes, while CVD-related mortality
was defined as death from any disease of the heart. The NCHS linked death records from the
National Death Index to the NHANES participants sequence numbers was utilized and mortality
status was determined for sample participants.
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PRIMARY INDEPENDENT VARIABLES
The primary independent variables in this study included cognitive function, social
support network size, and total physical activity volume (TPAV). Cognitive function was
assessed with the Digit Symbol Substitution Test (DSST) during the household interview of
NHANES participants. The DSST is a component of the Weschler Adult Intelligence Test which
assesses response speed, sustained attention, visual spatial skills, associative learning, and
memory (2, 3). The DSST requires participants to copy symbols which are paired with numbers
during a period of two minutes (3). Following the two-minute period, participants are scored
based on the number of correct symbols drawn during the time limit. Two files were utilized to
assess cognitive function within the NHANES. Cognitive Functioning Questionnaire File
CFDRIGHT indicated the number correct on the DSST and Cognitive Functioning Questionnaire
File CFD050 indicated DSST exercise completion. Quartiles of cognitive function were created
based on DSST completion and the number correct: < 34 correct, 34-46 correct, 47-57 correct,
and ≥ 58 correct.
Within NHANES, social support was assessed with questions from the Yale Health and
Aging Study and the Social Network Index – Alameda County Study during the household
interview. Social support network size was determined through the self-reported number of close
friends. The Social Support Questionnaire File SSQ060 was utilized to assess social support
network size. Social Support Questionnaire File SSQ060 asks participants, “In general, how
many close friends do you have? By “close friends” I mean relatives or non-relatives that you
feel at ease with, can talk to about private matters, and can call on for help.” Three categories of
social support were created: 0 reported close friends, 1-4 reported close friends, and ≥ 5 reported
close friends.
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TPAV was determined based on weekly MET values of aerobic physical activity across
three physical activity domains (4). Two files in NHANES were utilized to create this variable.
The Physical Activity Questionnaire file includes questions related to the frequency, intensity,
and duration of transportation and domestic physical activity performed over the past 30 days.
The Physical Activity Individual Activities Questionnaire file includes more detailed information
about specific moderate and vigorous leisure-time physical activity. Using the Compendium of
Physical Activity, MET values were assigned to each type of activity. Next, the average duration
(minutes per session) was multiplied by the average frequency (number of sessions per week)
and the intensity level (MET-level) to generate MET-minutes per week for each activity. METminutes per week were then summed for each domain of physical activity, resulting in the TPAV
variable. Quartiles of TPAV were subsequently created which included ≤ 249 METminutes/week, 250-755 MET-minutes/week, 756-1,000 MET-minutes/week, and > 1,000 METminutes/week.
OTHER INDEPENDENT VARIABLES
Other variables were controlled for in this study to prevent any potential confounding.
These variables included:
AGE
Age was dichotomized as 60-70 years of age and > 70 years of age.
EDUCATION
Education was divided into three categories which included less than high school, high
school graduate, and more than high school.
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RACE
Race was divided into four categories which included non-Hispanic white, non-Hispanic
Black, Mexican American, and other including multi-racial and other Hispanic.
BLOOD PRESSURE
Blood pressure was divided into four categories based on the 2017 American College of
Cardiology and American Heart Association Guidelines as: normal SBP < 120 mmHg and DBP
< 80 mmHg, elevated SBP 120-129 mmHg and DBP < 80 mmHg, Stage 1 Hypertension SBP
130-139 mmHg and DBP 80-89 mmHg, and Stage 2 Hypertension SBP ≥ 140 mmHg and DBP ≥
90 mmHg (5). Stage 1 and Stage 2 Hypertension were also based on responses to Blood Pressure
& Cholesterol Questionnaire File BPQ050a, “Now taking prescribed medicine for high blood
pressure.”
WAIST CIRCUMFERENCE
Waist circumference was dichotomized based on the U.S. Department of Health and
Human Services classifications of overweight and obesity (6). An elevated waist circumference
was defined as ≥ 102 cm and ≥ 88 cm for men and women, respectively.
GLYCOHEMOGLOBIN
Glycohemoglobin was divided into three categories based on recommendations by the
American Diabetes Association which included < 5.7%, 5.7-6.4%, and ≥ 6.5% (7).
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SERUM COTININE
Tobacco use was dichotomized based on serum cotinine levels where a serum cotinine
level < 3 ng/mL represented non-smoking level and a serum cotinine level ≥ 3 mg/mL indicated
current tobacco use or current exposure (8).
STATISTICAL ANALYSIS
The data in this study was managed using SAS (Version 9.4; SAS Institute, Inc., Cary,
NC) (9). SAS was used to conduct complex variable recording, data coding validation, and to
conduct the analysis incorporating sampling weights within the context of the correlated multistage complex design inherent to the NHANES. Descriptive characteristics were obtained with
the means (PROC SURVEYMEANS) and frequency (PROC SURVEYFREQ) procedures for
continuous and categorical variables, respectively.
Cox proportional hazards regression analysis was performed with the PROC
SURVEYPHREG procedure to determine whether social support network size and TPAV
mediate the risk of all-cause and CVD-related mortality according to quartile of cognitive
function. A forward selection process based on the results of the Cox proportional hazards
regression analysis was used to generate three models for analysis. These included a crude
Model 1, Model 2 adjusted for select demographic factors including sex, education, race, and
age, and Model 3 adjusted for Model 2 covariates and blood pressure, smoking status, waist
circumference, and glycohemoglobin.
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Abstract
BACKGROUND: Low cognitive function has been shown to be an independent predictor of
all-cause and cardiovascular disease (CVD)-related mortality. Social support network size and
total physical activity volume (TPAV) are two modifiable factors which have been shown to be
independently associated with cognitive function and mortality risk. Therefore, the purpose of
this study was to examine the potential mediating effects of social support network size and
TPAV on cognitive function and all-cause and CVD-related mortality risk in a large, nationally
representative sample of U.S. adults.
METHODS: Study sample (N =2,550) included older adult (≥ 60 years of age) participants in
the 1999-2002 National Health and Nutrition Examination Survey. Quartiles of cognitive
function were created using Digit Symbol Substitution Test scores. Social support network size
was determined using the number of reported close friends. TPAV was determined from selfreported domestic, transportation, and leisure time physical activity.
RESULTS: Regression analysis revealed an approximate three-fold increase in all-cause and
CVD-related mortality risk in participants in the lowest quartile of cognitive function, compared
to the highest quartile of cognitive function. These relationships are independent of social
support network size and TPAV. Linear and non-linear inverse dose-response relationships were
also revealed between cognitive function and increased all-cause and CVD-related mortality risk,
respectively (P for trend for both P < 0.0001).
CONCLUSION: In a large, nationally representative sample of U.S. older adults, low cognitive
function was associated with increased all-cause and CVD-related mortality risk. However, both
relationships were independent of social support network size and TPAV.

56
Introduction
Changes in cognitive function, including declines in speed of processing, working
memory, and executive function, are part of the normal aging process (1). In the brain, structural
and functional changes occur which account for these age-related changes, including loss of
synapses, dysfunction of neuronal networks, and alterations in neuronal structure without
neuronal death. Various factors such as cerebral ischemia, head trauma, toxin exposure, or
excess stress hormones can cause damage to the brain throughout the aging process and produce
cognitive impairments leading to declines in cognitive function.
Declines in cognitive function often occur in individuals ages 65-85 years of age and
maintaining cognitive function in older adulthood has important implications for longevity (2).
Cognitive function has been shown to be predictive of all-cause and cardiovascular disease
(CVD)-related mortality in middle-aged and older populations (3-6). Low cognitive function has
also been shown to be associated with increased all-cause mortality risk independent of several
CVD-related biomarkers (i.e., elevated mean arterial pressure, high-sensitivity C-reactive
protein, high density lipoprotein-cholesterol [HDL-C], total cholesterol, glycosylated
hemoglobin [HbA1c], and body mass index) in older adults (4). Changes in cognitive function
have also been shown to influence mortality risk as a decline in cognitive ability has been shown
to be predictive of all-cause mortality independent of depression and other risk factors (3).
Collectively, this previous evidence has established cognitive function as an independent
predictor of mortality. The likelihood of low cognitive function and cognitive decline is more
common in an aging population (7). Globally, the population of adults aged 65 years and older is
growing at a rapid rate (8). By 2050, it is projected that one in six people in the world will be
over the age of 65 and the number of persons 80 years and older is projected to triple from 143
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million in 2019 to 426 million in 2050. Consequently, the importance of identifying factors that
may mediate the relationship between cognitive function and mortality risk remains an important
research area due to the rapid growth of the older adult population across the globe.
Physical activity (PA) is defined as any bodily movement produced by skeletal muscles
which results in energy expenditure (9). Physical activity has been shown to be independently
associated with both cognitive function and mortality risk (10, 11). Physical activity has been
posited to attenuate cognitive decline through its actions to raise HDL-C, lower systolic blood
pressure, and generally reduce CVD-related risk (10). In older adults, PA has been shown to be
inversely associated with all-cause mortality risk (11). Physical activity has been suggested to
reduce mortality risk through both physiological and behavioral mechanisms, including
improved fibrinolytic activity, hemostatic function, glucose tolerance, lipid profile, blood
pressure, inflammation, and oxidative stress (10). Physical activity may also attenuate mortality
risk through actions that promote improved coping with stressful life events and reduce
depression. Therefore, due to the beneficial impact of increased PA on both cognitive function
and mortality risk, PA may be an important mediator of the association between cognitive
function and mortality risk.
Social relationships are another factor which have been shown to be independently and
beneficially associated with both cognitive function and mortality (12-14). Social relationships
can be defined as either functional or structural. Functional social relationships (e.g., social
support) have been defined as the social and emotional resources that people have or perceive as
available to them, while structural social relationships (e.g., social support network size, social
integration) reflect the quantitative characteristics of social relationships and refer to
participation in a broad range of social relationships (15). A positive association between social
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support network size and cognitive function has been reported in older adults, illustrating the
importance of structural social relationships (15-17). Functional social relationships also
influence cognitive function as social support has been linked to better cognitive functioning and
less cognitive decline (12, 19-20). In older adults, greater baseline emotional support has been
shown to be a significant predictor of better cognitive function over 7.5 years of follow up (12).
The interactional brain hypothesis has been proposed to account for the beneficial
association between social support and cognitive function. This hypothesis suggests that
interactions with others are a fundamental component of brain development and cognitive
processes (21). Moreover, social interaction has been proposed to play a crucial role in the
emergence of cognition, as observed with processes shaped by cultural rather than genetic
evolution (e.g., imitation, mentalizing, and language) (22).
Functional and structural social relationships also have important implications for
mortality risk. In a meta-analysis of 50 studies examining the associations between social support
and all-cause mortality risk, it has been reported that individuals with lower levels of social
support exhibited a significant increase in all-cause mortality risk (13). However, mortality risk
is attenuated in individuals with greater levels of social support. It has been found that
participants who reported social support from family and social support from a spouse/partner
exhibited significant reductions in all-cause mortality risk, illustrating the importance of
functional social relationships (23).
While the presence of social support (i.e., functional social relationships) has been shown
to attenuate mortality risk, evidence suggests that social integration (i.e., structural social
relationships) may exert a greater protective effect. When examining the association of
functional and structural social relationships with mortality risk, it has been reported that social
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integration (i.e., a measure of structural social relationships) is associated with a significant
reduction in all-cause and cause-specific mortality risk, while the same association was not
observed for social support (i.e., a measure of functional social relationships) (15, 24). Therefore,
while both functional and structural social relationships have important implications for
mortality risk, structural social relationships may be a stronger predictor of mortality.
Moreover, PA and social relationships have been shown to be associated with both
cognitive function and mortality independently (10-13). However, there is limited evidence
examining whether PA or social support network size mediate the relationship between cognitive
function and mortality risk. Accordingly, the purpose of this study was to examine the potential
mediating effects of social support network size and total PA volume (TPAV) on cognitive
function and all-cause and CVD-related mortality risk in a large, nationally representative
sample of U.S. older adults. It was hypothesized that social support network size and TPAV
mediate the relationship between cognitive function and mortality risk, due to the independent
associations between the variables (10-13).
Methods
Study Population
This study utilized four years of data from the 1999-2002 National Health and Nutrition
Examination Survey (NHANES). The NHANES is a continuous survey conducted by the
National Center for Health Statistics (NCHS) which combines personal interviews with
standardized physical examinations and laboratory tests (25). The NHANES collects data about
the health, nutritional status, and health behaviors of the non-institutionalized population of the
U.S. (0 months and older) (26). The NHANES uses a complex, multistage probability sampling
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design to obtain a representative sample of the U.S. population. Participants in this study
completed an informed consent and met the following inclusion criteria: were ≥ 60 years of age,
attended the mobile examination center, were not pregnant, and individuals with complete data
on all variables of interest. The final sample included 2,550 U.S. adults ≥ 60 years of age.
Cognitive Function
Cognitive function was assessed using the Digit Symbol Substitution Test (DSST). The
DSST is a component of the Wechsler Adult Intelligence Scale (WAIS) and requires response
speed, sustained attention, visual spatial skills, associative learning, and memory (27). The DSST
is a valid and sensitive measure of cognitive dysfunction which is impacted by several domains.
Performance on the DSST correlates with functional outcomes (i.e., ability to perform activities
of daily living) and recovery from functional disability in various psychiatric conditions (e.g.,
schizophrenia and major depressive disorder). Within the NHANES, the DSST was chosen as a
measure of cognitive function because it may be a more sensitive measure of cognitive function
than the Mini-Mental State Examination (MMSE) and it has also been previously administered
in the National Institute on Aging’s Health ABC study (28, 29).
The DSST testing protocol requires participants to copy symbols which are paired with
numbers during a period of two minutes (27). The initial duration of the DSST was 90 seconds.
However, this duration was increased to two minutes with the creation of the third edition of the
WAIS. Following the two-minute testing period, participants are scored based on the number of
correct symbols successfully drawn during the time limit. Quartiles of cognitive function were
created based on the number correct: < 34 correct, 34-46 correct, 47-57 correct, and ≥ 58 correct.
Total Physical Activity Volume
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Total PA volume was determined based on weekly metabolic equivalent (MET) values
for aerobic PA across three domains (i.e., leisure-time PA [LTPA], transportation PA, and
domestic PA) (30). First, the frequency, intensity, and duration of transportation and domestic
PA performed over the past 30 days was determined for each participant. The Compendium of
PA MET values were then assigned to each type of activity (31). The average duration (minutes
per session) was then multiplied by the average frequency (number of sessions per week) and the
intensity level (MET-level) to create MET-minutes per week for each activity. MET-minutes per
week were summed for each domain of PA to create the TPAV variable. Quartiles of TPAV
included ≤ 249 MET-minutes/week, 250-755 MET-minutes/week, 756-1,000 METminutes/week, and > 1,000 MET-minutes/week.
Social Support Network Size
The social support portion of the NHANES was conducted during the household
interview using questions selected from the Yale Health and Aging Study and the Social
Network Index – Alameda County Study (32). Social support network size was determined using
the question, “In general, how many close friends do you have? By “close friends” I mean
relatives or non-relatives that you feel at ease with, can talk to about private matters, and can
call on for help” (12, 33-34). Three categories of social support were created: none, 1-4, and ≥ 5
close friends.
Covariates
Age was dichotomized as 60-70 years of age and > 70 years of age. Three categories of
education were used which included less than high school, high school graduate, and more than
high school. Four categories of race/ethnicity were utilized which included non-Hispanic white,
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non-Hispanic Black, Mexican American, and other including multi-racial and other Hispanic.
Blood pressure was divided into four categories based upon the 2017 American College of
Cardiology and American Heart Association guidelines: normal (SBP [Systolic Blood Pressure]
≤ 120 mmHg and DBP [Diastolic Blood Pressure] ≤ 80 mmHg), elevated (SBP 120-129 mmHg
and DBP ≤ 80 mmHg), Stage 1 Hypertension (SBP 130-139 mmHg and DBP 80-89 mmHg) and
Stage 2 Hypertension (SBP ≥ 140 mmHg and DBP ≥ 90 mmHg) (35). Waist circumference
(WC) was dichotomized based on the 2013 Systematic Evidence Review from the Obesity
Expert Panel (36). Waist circumference was categorized as elevated at ≥ 102 cm and ≥ 88 cm,
for men and women, respectively. The three categories of HbA1c analyzed were based on
recommendations by the American Diabetes Association which included < 5.7%, 5.7-6.4%, and
≥ 6.5% (37). Active smoking and environmental tobacco smoke exposure was assessed with
serum cotinine levels, a metabolite of nicotine. Serum cotinine levels were dichotomized based
on having a serum cotinine level ≥ 3 ng/mL (38).
Mortality
The dependent variables in this study were all-cause and CVD-related mortality. The
NCHS linked death records from the National Death Index to the 1999-2002 NHANES
participants using a process outlined elsewhere (39). The cause of death was determined and
classified by the International Statistical Classification of Diseases, Injuries, and Causes of
Death-10 codes for participants who were identified as deceased. All-cause mortality was
defined as death from all causes, while CVD-related mortality only included death from diseases
related to the heart.
Statistical Analysis
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The data in this study was managed using SAS Version 9.4 (SAS Institute, Inc., Cary,
NC) (40). SAS was utilized to conduct complex variable recodes, data coding validation, and to
conduct the analysis incorporating sampling weights within the context of the correlated multistage complex design inherent to the NHANES. Mean (PROC SURVEYMEANS) and frequency
(PROC SURVEYFREQ) procedures were used to generate descriptive statistics for continuous
and categorical variables, respectively. Cox proportional hazards regression analyses were
performed using the PROC SURVEYPHREG procedure. The models analyzed included a crude
Model 1, Model 2 adjusted for demographic factors including age, race/ethnicity, sex, and
education, and a fully-adjusted Model 3 adjusted for Model 2 covariates, blood pressure, serum
cotinine, WC, and HbA1c.
Results
The study characteristics of the participants according to quartiles of cognitive function
are summarized in Table 1. The mean age of participants in the highest quartile of cognitive
function was significantly (P < 0.05) lower than the mean age of participants in the other three
quartiles of cognitive function. The greatest proportion of female participants was also found in
the highest quartile of cognitive function. While 9.5% of the participants in the highest quartile
of cognitive function had less than a high school education, 70.3% of participants in the lowest
quartile of cognitive function had less than a high school education. Participants in the highest
quartile of cognitive function also had significantly (P < 0.05) lower mean HbA1c levels when
compared to participants in the lowest quartile of cognitive function.
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Table 1. Study Characteristics of U.S. Adults ≥ 60 years of age: NHANES 1999-2002
(N=2,550).
Point
Estimate
(95% CI)

N, % of total sample
Age, mean, years
Gender, % female
Race-ethnicity, % nH white
Education, % less than high
school
Elevated serum cotinine
concentration, %

Cognitive
Function
Quartile 1
875 (34.3)

Cognitive
Function
Quartile 2
649 (25.5)

Cognitive
Function
Quartile 3
500 (19.6)

Cognitive
Function
Quartile 4
526 (20.6)

73.9 (73.074.9)
45.8
39.5

71.7 (71.172.4)
48.5
61.6

70.0 (69.170.9)
54.6
72.4

67.0 (66.467.6)
58.9
81.0

70.3

38.2

20

9.5

17.9

16.2

14.2

11.6

105.1 (103.5106.7)
96.0 (94.597.5)
5.92 (5.816.04)
40.1 (39.840.3)
57.5

105.1 (103.1107.0)
97.6 (95.899.5)
5.74 (5.635.85)
52.2 (51.852.5)
47.8

103.8 (102.5105.1)
94.8 (93.296.3)
5.59 (5.525.67)
68.0 (67.468.5)
41.3

3.7
34.8
61.5

4.0
28.6
67.4

1.2
28.1
70.7

Waist Circumference, mean,
cm
Men 102.1 (100.6103.6)
Women 97.4 (95.599.2)
Glycohemoglobin, mean %
5.95 (5.826.08)
DSST, mean, number correct 23.6 (22.824.5)
Total Weekly Physical
66.5
Activity Volume, % in
lowest quartile of TPAV
Network Size, close friends,
%

0 6.7
1-4 45.3
≥ 5 48.0
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Results of the Cox proportional hazards regression analysis examining the potential
mediating effects of TPAV and social support network size on all-cause mortality risk are shown
in Table 2. Crude analysis revealed a significant increase in all-cause mortality risk in the three
lowest quartiles of cognitive function, independent of social support network size and TPAV. An
approximate 3.5-fold (P < 0.0001) increase in all-cause mortality risk was observed in
participants in the lowest quartile of cognitive function when compared to a referent group with
participants in the highest quartile of cognitive function. A 2.6-fold (P < 0.0001) and 1.7-fold (P
< 0.01) increase in all-cause mortality risk was observed in participants in the second quartile of
cognitive function and in participants in the third quartile of cognitive function, respectively.
After adjusting for select demographic factors including sex, education, race/ethnicity, and age,
all-cause mortality risk was slightly attenuated but remained significant in participants in the
three lowest quartiles of cognitive function, independent of social support network size and
TPAV. After full adjustment for metabolic and lifestyle risk factors, a significant increase in allcause mortality risk was maintained in participants in the three lowest quartiles of cognitive
function, regardless of social support network size and TPAV. An approximate three-fold (P <
0.0001) increase in all-cause mortality risk was observed in participants in the lowest quartile of
cognitive function, while participants in the second quartile of cognitive function exhibited a
two-fold (P < 0.0001) increase in all-cause mortality risk. A linear inverse dose-response
relationship was also revealed between low cognitive function and increased all-cause mortality
risk (P < 0.0001 for trend).

66
Table 2. Potential Mediating Effects of TPAV and Social Support on All-Cause Mortality Risk

Cognitive Function
Group 1
Cognitive Function
Group 2
Cognitive Function
Group 3
Cognitive Function
Group 4

Model 1 HRa (95%
CI)
3.57 (2.97-4.30)*

Model 2 HRb (95%
CI)
2.93 (2.38-3.61)*

Model 3 HRc (95%
CI)
2.89 (2.33-3.59)*

2.60 (1.99-3.38)*

2.05 (1.57-2.69)*

2.06 (1.57-2.71)*

1.69 (1.32-2.17)**

1.44 (1.14-1.82)**

1.39 (1.09-1.78)**

1.00

1.00

1.00

a

Unadjusted crude model.

b

Adjusted for gender, education, race, and age.

c Adjusted

for gender, education, race, age, blood pressure, smoking status, waist circumference,
and glycohemoglobin.
*P < 0.0001
**P < 0.01

Table 3 illustrates the results of the Cox proportional hazards regression analysis
examining the potential mediating effects of TPAV and social support network size on CVDrelated mortality risk. Crude analysis revealed a significant increase in CVD-related mortality
risk in participants in the two lowest quartiles of cognitive function, independent of social
support network size and TPAV. An approximate three-fold and 2.4-fold (P < 0.01 for both)
increase in CVD-related mortality risk was observed in participants in the lowest quartile of
cognitive function and in participants in the second quartile of cognitive function, respectively.
However, no significant increase in CVD-related mortality risk was observed in participants in
the third quartile of cognitive function. A slight reduction in CVD-related mortality was
observed in these participants, however, the hazards ratio failed to reach statistical significance.
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After adjusting for select demographic factors (i.e., sex, education, race/ethnicity, and age), the
relationship was slightly attenuated but remained significant in participants in the lowest quartile
of cognitive function and in the second quartile of cognitive function. Similar to the crude
analysis, the relationship between cognitive function and CVD-related mortality was not
mediated by social support network size or TPAV. Following full adjustment for metabolic and
lifestyle risk factors, CVD-related mortality risk remained significant in participants in the
lowest quartile of cognitive function and in the second quartile of cognitive function,
independent of social support network size and TPAV (P < 0.01 for both). No significant
increases in CVD-related mortality risk were observed in participants in the third quartile of
cognitive function when compared to the highest quartile of cognitive function. A non-linear
inverse dose-response relationship was revealed between low cognitive function and increased
CVD-related mortality risk (P = 0.0002).
Table 3. Potential Mediating Effects of TPAV and Social Support on CVD-Related Mortality
Risk

Cognitive Function
Group 1
Cognitive Function
Group 2
Cognitive Function
Group 3
Cognitive Function
Group 4

Model 1 HRa (95%
CI)
2.96 (1.77-4.95)**

Model 2 HRb (95%
CI)
2.83 (1.61-4.99)**

Model 3 HRc (95%
CI)
2.67 (1.54-4.64)**

2.42 (1.42-4.13)**

2.18 (1.23-3.89)**

2.05 (1.21-3.49)**

0.90 (0.45-1.81)

0.82 (0.38-1.77)

0.78 (0.39-1.57)

1.00

1.00

1.00

a

Unadjusted crude model.

b

Adjusted for gender, education, race, and age.

c Adjusted

for gender, education, race, age, blood pressure, smoking status, waist circumference,
and glycohemoglobin.
**P < 0.01
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Discussion
Our findings suggest that low cognitive function is associated with a significant increase
in all-cause and CVD-related mortality risk, independent of TPAV and social support network
size. To our knowledge, this is the first study to examine whether social support network size and
TPAV mediate the relationship between cognitive function and mortality risk. This is also the
first to our knowledge that examines this relationship in a large and nationally representative
sample of the U.S. population.
In the present study, a significant increase in all-cause mortality risk was observed for
every quartile of cognitive function when compared to a referent group with the highest
cognitive function score (DSST score ≥ 58 correct), independent of social support network size
and TPAV. However, a significant increase in CVD-related mortality was only observed for
individuals in the first and second quartiles of cognitive function. This suggests that the
mechanisms relating cognitive function to an augmented mortality risk may differ based on
cause of death.
Differences in the association between cognitive function and mortality risk based on
cause of death have been reported (41, 42). In a 2018 prospective cohort study conducted by An
et al. examining the association between MMSE-assessed cognitive impairment and the risk of
all-cause and CVD-related mortality, the association between cognitive function and mortality
differed based on the type of mortality examined (41). Following full adjustment (i.e., including
exercise and marital status), these investigators reported a significant increase in CVD-related
mortality risk in participants in all quartiles of cognitive function when compared to a referent
group with the highest cognitive function (MMSE score 28-30). However, a significant increase
in all-cause mortality risk was only observed in participants in the first and second quartiles of
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cognitive function. Similar results were reported in a subsequent 2020 study conducted by
Tamosiunas et al. (6) who found that the risk of all-cause mortality was less significant compared
to CVD-related mortality and in a 2016 study conducted by Batty et al. (42) who reported that
the strength of the association between cognitive function and mortality differed based on cause
(i.e., cancer mortality, CVD-related mortality, respiratory illness mortality, and other causes).
These differences may be due in-part to differences in the populations analyzed, and the
assessments of cognitive function utilized. For example, An et al. (41) examined adults ≥ 55
years of age from the Beijing Longitudinal Study of Aging and Tamosiunas et al. (6) examined
adults 45-72 years of age from the Health, Alcohol, and Psychosocial Factors in Eastern Europe
study. The present study examined adults ≥ 60 years of age from the NHANES. Additionally,
An et al. (41) used the MMSE to assess cognitive function, while the present study used the
DSST. The MMSE is an index of global cognitive function, while the DSST assesses
components of executive function (i.e., response speed, sustained attention, visual spatial skills,
associative learning, and memory) (27). Some evidence suggests that executive function may be
a stronger predictor of mortality when compared to global cognitive function (43, 44).
The present study suggests that low cognitive function is an independent predictor of allcause and CVD-related mortality, independent of social support network size. In 2009, Obisesan
and Gillum examined the independent effects of structural social relationships (i.e., social
integration) and cognitive function on mortality risk in older adult participants (≥ 60 years of
age) in the third NHANES (45). Cognitive function was assessed with a short index of cognitive
function (SICF), which consisted of subsets of different cognitive screening instruments
including the MMSE, Short Portable Mental Status Questionnaire, and Weschler Adult
Intelligence Scale. Overall scores were determined for participants and quartiles of cognitive
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function were utilized. Structural social relationships were assessed using a social network index
comprising of marital status, frequency of contacts in domains of friends and relatives, religious
attendance, and voluntary associations. The social network index score ranged from 0-4 and
three categories were examined (i.e., 0-1, 2, and 3-4).
Following an average follow-up of 8.5 years, these investigators reported that mortality
risk was higher in those in the lowest quartile of cognitive function when compared to those in
the highest quartile of cognitive function, and in those with the lowest social integration index
compared to those with the highest social integration index. However, a significant interaction
between SICF score and structural social relationships was not revealed. This finding was similar
to the results of the present study as low cognitive function was associated an increased mortality
risk independent of structural social relationships (i.e., social support network size), indicating
that no interaction occurred between the two variables. Moreover, while structural social
relationships may be independently associated with cognitive function and mortality risk, they do
not mediate the association between these two variables based on the results of this study.
Subsequently, in 2010, Gillum and Obisesan examined how LTPA may modify the effect
of cognitive function on mortality risk in older adult participants in the third NHANES (10).
These investigators reported that both low cognitive function and a low LTPA volume were
independently associated with increased mortality risk. However, an interaction between
cognitive function and LTPA was not revealed, similar to the results of the present study.
Moreover, these previous studies support the evidence suggesting that cognitive function, social
relationhips, and PA relate to mortality risk independently. However, structural social
relationships and TPAV may be insufficient to account for the relationship between cognitive
function and mortality.
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Overall, the mechanisms relating low cognitive function to increased mortality risk
remain unclear. However, other possible mechanisms relating low cognitive function to an
increased mortality risk have been suggested. First, the relationship between cognitive function
and mortality risk may be explained by health literacy (6). Health literacy has been defined as the
skills required to access and synthesize health information and has been shown to be directly
associated with cognitive function (46). Health literacy relates to mortality as individuals with
low cognitive function and low health literacy may be less likely to seek appropriate medical
care and health information concerning the promotion and maintenance of good health (2).
Therefore, health literacy may be an important component for promoting longevity which may
be attenuated in individuals with low cognitive function.
Second, cognitive function may influence health and mortality risk through a multidimensional concept like frailty. Frailty is characterized by weight loss, exhaustion, weakness,
slow walking speed, and physical inactivity (47). Frailty has been shown to be directly associated
with cognitive impairment and frail elderly adults have been shown to be eight times more likely
to develop cognitive impairment, six times more likely to develop vascular dementia, and four
times more likely to develop dementia due to Alzheimer’s Disease.
The phenomenon of cognitive frailty has also recently been proposed. Cognitive frailty
has been characterized as a syndrome in older adults who develop both cognitive impairment
(i.e., without a clinical diagnosis of Alzheimer’s Disease or another dementia) and physical
frailty (48). Cognitive frailty also has implications for mortality risk. In a 2020 systematic review
and meta-analysis, a two-fold increase in all-cause mortality risk was observed in cognitively
frail individuals when compared to older adults without cognitive frailty (49). Lastly, low
cognitive function may be related to an increased mortality risk due to the beginning processes of
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the pathophysiology of dementia including vascular mechanisms such as micro-infarcts, microhemorrhages, strategic white matter tracts, loss of microstructural tissue integrity, and
neurodegeneration (50, 51).
Our results suggest that low cognitive function is associated with increased all-cause and
CVD-related mortality risk, independent of TPAV and social support network size. This finding
is in contrast with the proposed hypothesis suggesting that social support network size and
TPAV mediate the relationship between cognitive function and mortality risk. However, the
results of this study do suggest the importance of maintaining cognitive function throughout the
aging process and into older adulthood to promote longevity. The results of this study also
suggest that the DSST may be an important tool to use throughout the aging process due to the
prognostic value of DSST assessed cognitive function.
The present study is not without limitations. First, the use and operationalization of social
relationships was limited secondary to the nature of the NHANES. Within the NHANES,
participants are asked questions regarding whether they have anyone to help with emotional
support and who provides emotional support. Participants are also asked whether they needed
more emotional support in the past year. Lastly, participants are asked to report their number of
close friends. Due to the paucity of questions asked within the NHANES related to social
relationships, the self-reported number of close friends was chosen as an indicator of structural
social relationships. However, a more global measure of social relationships may provide greater
insight into the association between social relationships, cognitive function, and mortality risk.
Limitations of the present study also include the inability to track potential changes in cognitive
function between initial measurement and death. Additionally, causality cannot be established
due to the cross-sectional design of the study. A major strength of our study is the contribution
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that our findings make to the limited evidence examining whether social support network size
and TPAV mediate the relationship between cognitive function and mortality risk. Secondly, the
NHANES is a large, population-based, and nationally representative sample which allows results
to be generalized to the older U.S. adult population. Lastly, cognitive function was objectively
measured, which minimizes the effects of recall and reporting biases.
Conclusion
In a large, nationally representative sample of older adults, low cognitive function was
associated with an increased risk of all-cause and CVD-related mortality, independent of social
support network size and TPAV. These results support the importance of maintaining cognitive
function throughout the aging process to attenuate both all-cause and CVD-related mortality risk.
These results also provide support for clinicians utilizing the DSST, a measure of executive
function, to assess mortality risk in older adults.
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Appendix A: JOINT EFFECT OF COGNITIVE FUNCTION AND C-REACTIVE
PROTEIN ON ALL-CAUSE MORTALITY RISK: 1999-2002 NHANES
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Abstract
Purpose: Examine the joint effect of cognitive function and C-reactive protein (CRP) on allcause mortality risk in older U.S. adults.
Methods: Sample included 1,335 older adult (≥ 60 years of age) participants in the 1999-2002
National Health and Nutrition Examination Survey. A four-level variable was created using
cognitive function and CRP concentration. Mortality was assessed using National Center for
Health Statistics linked death records from the National Death Index.
Results: Increased risk of all-cause mortality was revealed in adults with high CRP and low
cognitive function and in those with low to average CRP and low cognitive function (P < 0.0001
for both). The joint effect of cognitive function and CRP on all-cause mortality risk differed
according to sex.
Conclusion: Low cognitive function was associated with increased all-cause mortality risk
independent of CRP concentration. Sex-stratified analyses revealed increased all-cause mortality
risk in males with low cognitive function, independent of CRP concentration. However, in
females, a significant increase in all-cause mortality risk was only observed in those with low to
average CRP and low cognitive function.
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Introduction
“Inflammaging” is characterized as a state of chronic low-grade inflammation, which is
associated with a significant increase in risk of morbidity and mortality in older populations (1).
C-reactive protein (CRP) is a non-specific biomarker for systemic inflammation and has been
shown to be related to the development of atherosclerosis and an increased risk of cardiovascular
disease (CVD)- related events and mortality (2-5). Elevated CRP is also associated with an
increased risk of cognitive decline (6-8), disability in activities of daily living, and reduced
functional capacity (9). In the brain, central inflammation results in synaptic remodeling,
neuronal apoptosis, and impaired neurogenesis which disrupts hypothalamic function and
impairs the outputs necessary for effective cognitive function (10).
Low cognitive function has been shown to be linked to an increased mortality risk in
middle aged and older populations (11-13). Therefore, both inflammation and cognitive function
have important implications for mortality risk throughout the aging process. It is also important
to examine whether biological sex modifies this relationship, as evidence suggests that sex
differences exist in the relationships between CRP, cognitive function, and mortality risk (1416). However, there is limited evidence examining whether sex differences exist when
examining the joint effect of CRP and cognitive function on mortality risk (2).
Since the likelihood of both decreased cognitive function (17) and increased
inflammation (18) are more common in an older population, examining the effects of cognitive
function, CRP concentration, and mortality risk in older adults remains an important research
area. The primary aim of this study was to examine the joint effect of cognitive function and
CRP on all-cause mortality risk in a large, nationally representative sample of United States
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(U.S.) older adults. The secondary aim was to examine the sex-stratified differences in this
relationship.
Methods
Study Population
This study utilized four years of data from the 1999-2002 National Health and Nutrition
Examination Survey (NHANES). The NHANES is a continuous survey conducted by the
National Center for Health Statistics to estimate the prevalence of and risk factors for major
diseases (19). The NHANES utilizes a complex, multistage probability sampling design to obtain
a representative sample of the noninstitutionalized U.S. population. Final sample included 749
and 586 male and female participants ≥ 60 years of age, respectively. Testing and examination
procedures were approved by the research and ethics review board of the National Center for
Health Statistics and all participants provided informed consent (20).
Covariates
Four categories of race/ethnicity were used: non-Hispanic White, non-Hispanic Black,
Mexican American, and other. Education was classified as less than high school, high school
graduate, and more than high school. Glycohemoglobin (HbA1c%) was divided into three
categories based on recommendations for the diagnosis of diabetes mellitus by the American
Diabetes Association: <5.7%, 5.7 to 6.4%, and ≥ 6.5% (21). Non-high-density lipoprotein
cholesterol (non-HDL-C), calculated by subtracting HDL-C from total cholesterol, was divided
into four categories: <130, 130-160, 160-190, and ≥ 190 mg/dL (22). Reduced HDL-C was
dichotomized (yes/no) for male participants (<40mg/dL, or drug treatment) and female
participants (<50 mg/dL, or drug treatment) (23). Elevated waist circumference (WC) was
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dichotomized (yes/no) based on the U.S Department of Health and Human Services
classifications of overweight and obesity for males (≥102 cm) and females (≥88cm) (24). Blood
pressure was categorized based on the 2017 American College of Cardiology and American
Heart Association guidelines (25). Total physical activity volume (TPAV) was determined based
on weekly MET values of aerobic PA across three PA domains (26).
Cognitive Function and CRP
Cognitive function was assessed using the Digit Symbol Substitution Test (DSST). The
DSST requires participants to copy symbols that are paired with numbers during a period of two
minutes. Participants are then scored by the number of correct symbols drawn within the time
limit. The DSST is a component of the Wechsler Adult Intelligence Test that requires response
speed, sustained attention, visual spatial skills, associative learning, and memory (27). Based on
the median DSST score (DSST value of 51), cognitive function was dichotomized as high
cognitive function (> 51 correct) or low cognitive function (≤ 51 correct) (12).
High-sensitivity CRP assays were performed on a Behring Nephelometer (Dade Behring
Diagnostics, Somerville, NJ) for quantitative CRP determination (28). CRP was dichotomized as
low to average CRP concentration (≤ 3 mg/L) and elevated CRP concentration (>3-10 mg/L).
The CRP ranges were based on risk stratification determined by the Center for Disease Control
and Prevention and the American Heart Association identifying both low risk and high-risk CRP
cut points (29). A four-level combined cognitive function and CRP variable was created: high
cognitive function and low to average CRP; high cognitive function and high CRP; low cognitive
function and low to average CRP; and low cognitive function and high CRP.
Mortality
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The National Center for Health Statistics linked death records from the National Death
Index to the 1999-2002 NHANES participants using a process outlined elsewhere (30). Cause of
death was determined and classified using the International Statistical Classification of Diseases,
Injuries, and Causes of Death-10 codes for participants who were identified as deceased. Allcause mortality was the primary dependent variable examined in this study.
Statistical Analysis
The data in this study were managed using SAS (Version 9.4; SAS Institute, Inc., Cary,
NC). SAS was used to conduct complex variable recodes, data coding validation, and to conduct
the analysis incorporating sampling weights within the context of the correlated multi-stage
complex design inherent to the NHANES. PROC SURVEYMEANS was used to produce mean,
median, quartiles, and 95% confidence intervals for covariates. Statistical significance was
assessed through the 95% confidence intervals produced using PROC SURVEYMEANS and
non-overlapping confidence intervals indicated statistical significance at P < 0.05. Weighted
prevalence estimates were produced using PROC SURVEYFREQ and Cox proportional hazard
ratios were produced using PROC SURVEYPHREG. Kaplan-Meier survival curves were
produced with PROC LIFETEST. Any participants who responded, “don’t know/not sure”,
refused to answer, or had missing responses for any of the questions or measures were excluded
from the final analysis. A forward selection process based on the results of the Cox proportional
hazards regression analysis was used to generate three models for analysis. These included a
crude Model 1, Model 2 adjusted for demographics including education, age, and race/ethnicity,
and Model 3 adjusted for all Model 2 covariates and CVD-related risk factors (i.e., smoking
status, non-HDL-C, HDL-C, HbA1c%, blood pressure, WC, and TPAV).
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Results
Table 1. Study Characteristics of Men ≥ 60 Years of Age: NHANES 1999-2002 (N = 749).
Point Estimate (95% CI*)
Variable

N, % of total sample
DSST, median number

High CRP and Low
Cognitive Function

151 (20.2)

High CRP and High
Cognitive Function

101 (13.5)

Low to Average CRP and
Low Cognitive Function

264 (35.2)

Low to Average CRP and
High Cognitive Function

233 (31.1)

34.0 (31.2-36.7)

56.8 (54.2-59.4)

35.3 (33.6-37.0)

59.6 (58.0-61.2)

%, nH-White

49.7

81.2

56.1

78.1

%, nH-Black

17.9

9.9

14.8

5.6

%, Mexican American

29.8

8.9

23.5

11.6

%, Other

2.6

0.0

5.6

4.7

751.6 (513.6-989.5)

566.2 (300.1-832.4)

564.4 (388.9-739.8)

634.2 (511.4-757.0)

25.2

19.8

17.8

11.2

WC, median, cm

105.0 (101.9-108.1)

105.5 (103.0-108.0)

102.2 (100.3-104.1)

101.5 (99.4-103.5)

Non-HDL-C, median, mg/dl

157.1 (147.8-166.5)

157.1 (151.2-163.1)

145.4 (140.2-150.7)

151.1 (144.6-157.6)

HDL-C, median, mg/dl

41.8 (39.4-44.1)

41.7 (39.5-43.8)

43.3 (40.7-45.8)

45.4 (42.8-45.8)

HbA1c, median %

5.60 (5.47-5.74)

5.54 (5.45-5.63)

5.49 (5.43-5.55)

5.39 (5.33-5.45)

Mortality, % died

63.6

41.6

60.2

33.9

correct
Race/ethnicity

Total Weekly Physical
Activity Volume, median,
MET/min/wk-1
Elevated serum cotinine
concentration**, %

*Non-overlapping confidence intervals indicate statistical significance at P < 0.05.
**Elevated serum cotinine concentration: serum cotinine ≥ 3 ng/ml.
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Table 2. Study Characteristics of Women ≥ 60 Years of Age: NHANES 1999-2002 (N = 586).
Variable

N, % of total sample
DSST, median number

High CRP and Low
Cognitive Function

115 (19.6)

High CRP and High
Cognitive Function

141 (24.1)

Low to Average CRP and
Low Cognitive Function

142 (24.2)

Low to Average CRP and
High Cognitive Function

188 (32.1)

34.4 (31.4-37.3)

59.9 (56.5-63.3)

34.3 (31.5-37.2)

58.2 (56.2-60.1)

%, nH-White

33.9

76.6

51.4

81.9

%, nH-Black

16.5

8.5

17.6

5.3

%, Mexican American

37.4

13.5

20.4

8.5

%, Other

12.2

1.4

10.6

4.3

250.0 (151.4-348.6)

521.3 (320.8-721.8)

587.8 (399.6-776.0)

496.3 (363.7-628.8)

9.6

9.2

14.8

11.7

WC, median, cm

96.3 (93.2-99.4)

97.8 (94.0-101.6)

92.3 (89.6-95.0)

90.8 (88.2-93.4)

Non-HDL-C, median, mg/dl

171.0 (162.7-179.4)

162.1 (155.1-169.2)

153.4 (139.4-167.4)

157.4 (151.5-163.2)

HDL-C, median, mg/dl

53.3 (48.5-58.1)

57.0 (53.6-60.4)

56.5 (52.0-61.0)

59.3 (55.6-62.9)

HbA1c, median %

5.54 (5.39-5.69)

5.37 (5.30-5.44)

5.43 (5.35-5.51)

5.35 (5.29-5.40)

Mortality, % died

43.5

29.8

50.0

30.3

correct
Race/ethnicity

Total Weekly Physical
Activity Volume, median,
MET/min/wk-1
Elevated serum cotinine
concentration**, %

*Non-overlapping confidence intervals indicate statistical significance at P < 0.05.
**Elevated serum cotinine concentration: serum cotinine ≥ 3 ng/ml.
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The study characteristics of the male and female participants according to CRP
concentration and cognitive function are summarized in Tables 1 and 2, respectively. Table 3
illustrates the results of the Cox proportional hazards regression analysis examining the
association between cognitive function, CRP concentration, and all-cause mortality risk. Crude
analysis revealed an approximate 3-fold (P < 0.0001) increase in all-cause mortality risk in
participants with low cognitive function and high CRP when compared to a referent group with
high cognitive function and low to average CRP. Following adjustment for demographic factors,
the risk of all-cause mortality was slightly attenuated but remained statistically significant in
participants with low cognitive function and low to average CRP and with low cognitive function
and high CRP (P < 0.0001 for both). A significant increase in all-cause mortality risk was
maintained in participants with low cognitive function, regardless of CRP concentration (P <
0.0001 for both) following full adjustment.
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Table 3. Combined Effect of Cognitive Function and CRP on All-Cause Mortality Risk in U.S.
Adults ≥ 60 Years of Age: NHANES 1999-2002.
Variable

Model 1 HRa (95% CI)

Model 2 HRb (95% CI)

Model 3 HRc (95% CI)

High Cognitive
Function and Low to
Average CRP
High Cognitive
Function and High
CRP
Low Cognitive
Function and Low to
Average CRP
Low Cognitive
Function and High
CRP

1.00

1.00

1.00

1.17 (0.87-1.56)

1.09 (0.81-1.47)

1.10 (0.83-1.47)

2.50 (1.97-3.17)*

1.92 (1.51-2.43)*

1.78 (1.38-2.29)*

2.63 (2.01-3.44)*

2.30 (1.78-2.99)*

2.37 (1.82-3.09)*

Unadjusted crude model. b Adjusted for education, age, and race/ethnicity. c Adjusted for
education, age, race/ethnicity, smoking status, non-HDL-C, HDL-C, HbA1c%, blood pressure,
WC, and TPAV.
a

*P < 0.0001.

Table 4 illustrates the results of the Cox proportional hazards regression analysis
stratified by sex. Crude analysis revealed a 3-fold (P < 0.0001 for both) increase in all-cause
mortality risk in male participants with low cognitive function and low to average CRP and in
male participants with low cognitive function and high CRP. After adjusting for demographic
factors, all-cause mortality risk was slightly attenuated but remained significant in male
participants with low cognitive function and low to average CRP and in male participants with
low cognitive function and high CRP (P < 0.0001 for both). Significance was maintained in
those with low cognitive function after adjusting for CVD-related risk factors, regardless of CRP
concentration.
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In female participants, crude analysis revealed an approximate 2-fold increase in allcause mortality risk in participants with low cognitive function and low to average CRP and in
participants with low cognitive function and high CRP. After adjusting for demographic factors,
all-cause mortality risk was attenuated but remained significant in female participants with low
cognitive function and low to average CRP (P < 0.01) and in female participants with low
cognitive function and high CRP (P < 0.05). After adjusting for CVD-related risk factors, a
significant increase in all-cause mortality risk only remained in female participants with low
cognitive function and low to average CRP (P < 0.05). A significant increase in all-cause
mortality risk was not observed in female participants with low cognitive function and high CRP
following adjustment for CVD-related risk factors.

93
Table 4. Combined Effect of Cognitive Function and CRP on All-Cause Mortality Risk
according to Sex in U.S. Adults ≥ 60 Years of Age: NHANES 1999-2002.

Men

Women

Variable
High Cognitive
Function and Low to
Average CRP

Model 1
1.00

Model 2
1.00

Model 3
1.00

High Cognitive
Function and High
CRP
Low Cognitive
Function and Low to
Average CRP

1.47 (0.93-2.34)

1.33 (0.81-2.20)

1.26 (0.74-2.13)

2.69 (1.94-3.74)*

1.73 (1.18-2.54) **

1.67 (1.10-2.54)***

Low Cognitive
Function and High
CRP

3.34 (2.32-4.81)*

2.67 (1.81-3.94) *

2.74 (1.82-4.12)*

High Cognitive
Function and Low to
Average CRP

1.00

1.00

1.00

High Cognitive
Function and High
CRP

1.00 (0.63-1.58)

0.97 (0.60-1.57)

0.96 (0.61-1.53)

Low Cognitive
Function and Low to
Average CRP

2.24 (1.57-3.18)*

1.90 (1.29-2.80)**

1.71 (1.14-2.59)***

Low Cognitive
Function and High
CRP

1.99 (1.17-3.41)***

1.89 (1.02-3.50)***

1.75 (0.90-3.43)

Unadjusted crude model. b Adjusted for sex, education, age, and race/ethnicity. c Adjusted for
age, sex, education, race/ethnicity, smoking status, non-HDL-C, HDL-C, HbA1c%, blood
pressure, WC, and TPAV.
a

* P < 0.0001

** P < 0.01
***P < 0.05
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Figure 1 illustrates the Kaplan-Meier survival curves for male participants stratified by
the cognitive function-CRP variable. A significant difference in mortality was observed (logrank test, P < 0.0001) between male participants with high cognitive function and male
participants with low cognitive function. Figure 2 illustrates the Kaplan-Meier survival curves
for female participants, indicating a significant difference (log-rank test, P = 0.0001) in mortality
among the four groups, with the greatest mortality observed in female participants with low
cognitive function and low to average CRP.

Figure 1. Kaplan-Meier survival curves for U.S. older adult male participants stratified by the
four-level joint cognitive function-CRP variable. Cognitive Function-CRP 1 (low cognitive
function and high CRP), Cognitive Function-CRP 2 (high cognitive function and high CRP),
Cognitive Function-CRP 3 (low cognitive function and low to average CRP), Cognitive
Function-CRP 4 (high cognitive function and low to average CRP).
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Figure 2. Kaplan-Meier survival curves for U.S. older adult female participants stratified by the
four-level joint cognitive function-CRP variable. Cognitive Function-CRP 1 (low cognitive
function and high CRP), Cognitive Function-CRP 2 (high cognitive function and high CRP),
Cognitive Function-CRP 3 (low cognitive function and low to average CRP), Cognitive
Function-CRP 4 (high cognitive function and low to average CRP).
Discussion:
Our findings suggest that low cognitive function is associated with a statistically
significant increase in all-cause mortality risk independent of CRP concentration. Sex-stratified
analyses revealed a significant increase in all-cause mortality risk in male participants with low
cognitive function, regardless of CRP concentration. However, a significant increase in all-cause
mortality risk in female participants was only observed in those with low cognitive function and
low to average CRP following full adjustment. Our findings add to the limited evidence
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suggesting low cognitive function is an independent predictor of increased all-cause mortality
risk in older adults, independent of CRP concentration. These findings also add to the paucity of
evidence suggesting sex differences may exist when examining the joint effect of CRP and
cognitive function on mortality risk (2).
Our findings are similar to those reported in a 2019 prospective cohort study conducted
by Chen et al. which found an increased mortality risk in older adults with low cognitive
function, regardless of CRP concentration. These investigators examined the joint effect of CRP
concentration and cognitive performance on all-cause mortality risk in adults (≥ 80 years of age)
in the Chinese Longitudinal Healthy Longevity Survey using a four-level joint CRP and
cognition variable (i.e., cognitive function was dichotomized as cognitive impairment and
normal cognition based on results of the Mini-Mental Status Examination (MMSE)). These
investigators reported a 2.4-fold and a 3.6-fold increase in all-cause mortality risk in participants
with CRP concentrations ≤ 3.0 mg/L and cognitive impairment and in participants with a CRP
concentration > 3.0 mg/L and cognitive impairment, respectively. These results are similar to
those reported in the present study as no significant differences in all-cause mortality risk were
observed based on CRP concentration in those with low cognitive function.
These investigators also reported that participants with a CRP concentration > 3 mg/L
and normal cognition had a 70% increase in all-cause mortality risk, compared to a referent
group with CRP concentration ≤ 3.0 mg/L and normal cognition. These results contrast with
those of the present study, as a significant increase in all-cause mortality risk was not revealed in
participants with high cognitive function and high CRP (CRP > 3 mg/L). This may be due to
differences in the populations analyzed and the measures of cognitive function utilized. The
population examined by Chen et al. (2019) included Chinese oldest-old adults (≥ 80 years of
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age). Our study examined older adult (≥ 60 years of age) NHANES participants. Additionally,
Chen et al. (2019) assessed cognitive function using the MMSE; cognitive function was assessed
using the DSST in the present study. The MMSE is an index of global cognitive function; while
the DSST assesses components of executive function (27, 31). This is noteworthy because some
evidence suggests that executive function may be a stronger predictor of mortality when
compared to global cognitive function (32, 33).
The results of the present study also expand upon previous literature examining the joint
effects of CVD risk and cognitive function on all-cause mortality risk. In 2017, Loprinzi et al.
similarly examined the joint effects of CVD risk factors, using a variable that included CRP
concentration, and DSST-assessed cognitive function on all-cause mortality risk among older
adult (≥ 60 years of age) participants in the 1999-2002 NHANES (12). These investigators
reported that low cognitive function (DSST score < 42) was associated with a two-fold increase
in all-cause mortality risk, independent of CVD risk. Our study expands on this finding,
illustrating that low cognitive function is associated with augmented all-cause mortality risk,
independent of CRP as an isolated CVD risk factor. Therefore, although an aggregate of risk
factors may lead to compounding effects on mortality risk, it remains important to examine
isolated CVD risk factors.
The associations between cognitive function, CRP, and mortality risk may also be
modified by sex. Doran et al. (2013) examined the relationship between increased CRP and
mortality risk using sex-stratified analyses (15). These investigators reported that males with
CRP concentrations > 3.0 mg/L had a 57% increase in all-cause mortality risk compared to those
with a CRP ≤ 3.0 mg/L. A similar statistically significant increase in all-cause mortality risk was
not observed in females. In 2015, Perna et al. examined the association between cognitive
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impairment and all-cause and cause-specific mortality (16). Cognitive impairment was assessed
by the Cognitive Telephone Screening Instrument (COGTEL), with higher scores indicating
greater cognitive function. No significant increases in all-cause mortality risk were observed in
females with low COGTEL scores, however, a 90% increase in all-cause mortality risk was
observed in males with low COGTEL scores. Although these studies examined CRP
concentration and cognitive function as independent predictors of mortality risk, these results
suggest that sex differences in the associations between CRP concentration, cognitive function,
and mortality risk exist. The results of the present study expand on these findings, suggesting
that sex differences also exist concerning the joint effect of cognitive function and CRP
concentration on mortality risk.
When examining the combined associations of CRP concentration and cognitive function
according to sex, Chen et al. (2019) reported that mortality risk was stronger in males (2).
Among those with a CRP concentration > 3 mg/L and cognitive impairment, females had an
approximate 3-fold increase in all-cause mortality risk, while males had a 4.3-fold increase in allcause mortality risk. These findings were similar to those presented, as the combined effect of
CRP and cognitive function on all-cause mortality risk was also stronger in males. However, in
contrast to the findings of Chen et al. (2019), our fully-adjusted analyses suggests that female
participants with high CRP concentration and low cognitive function do not possess statistically
significantly increased all-cause mortality risk. This may have occurred due to gender
differences in baseline CRP concentration. Higher baseline CRP values have been observed in
women when compared to men (15, 34). Additionally, an elevation from one’s baseline, rather
than an absolute value, may be an important consideration when examining the association
between CRP concentration and mortality risk in women (15).
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The findings of this study are important because it suggests that maintaining cognitive
function may be an important consideration for improved longevity. The findings also suggest
that DSST-assessed cognitive function may be a powerful prognostic tool when assessing
mortality risk in older adults. Our study adds to the limited evidence examining sex differences
in the joint association between cognitive function and CRP concentration on all-cause mortality
risk. Our findings revealed that males with low cognitive function have a greater risk of all-cause
mortality, independent of CRP concentration. However, in females, a significant increase in risk
was only observed in those with low cognitive function and low to average CRP concentration.
These findings suggest that sex differences may exist when examining the joint effect of
cognitive function and CRP concentration on all-cause mortality risk.
The strengths of our study include the contribution our findings make to the limited
evidence examining the joint effect of cognitive function and CRP concentration on all-cause
mortality risk and the sex differences in this relationship. Second, the NHANES includes a large,
population-based, nationally representative sample which allows results to be generalized to the
older U.S. adult population. Lastly, cognitive function was objectively measured, minimizing the
effects of recall and reporting biases. The present study also includes some inherent limitations.
The potential changes in cognitive function between initial measurement and death are not
assessed. Additionally, cause-specific mortality was not assessed in the present study. The effect
of low cognitive function on all-cause mortality risk may differ for CVD or diabetes-related
mortality and requires further examination.
Conclusion
Our results revealed that in a large, nationally representative sample of older U.S. adults,
low cognitive function was associated with a statistically significant increase in all-cause
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mortality risk, independent of CRP concentration. Our results also indicate that sex differences
may exist when examining the joint effects of cognitive function and CRP concentration on allcause mortality risk.
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